Prostate cancer treatment may protect from COVID-19

Even if men did not have prostate cancer could take androgen-​deprivation therapies to prevent infection

11-May-2020 - Androgen-​deprivation therapy could protect against infection with SARS-​CoV-2 and against severe disease progression. This is suggested by a study led by a professor from the Università della Svizzera Italiana and ETH Zurich. Male cancer patients have a 1.8-​fold increased risk of COVID-​19 ...

Breast cancer can form 'sleeper cells' after drug treatment

04-Sep-2019 - Breast cancer medicines may force some cancer cells into 'sleeper mode', allowing them to potentially come back to life years after initial treatment. These are the early-stage findings from scientists at Imperial College London, who studied human breast cancer cells in the laboratory. The team, ...

Moffitt develops novel cancer treatment to inhibit chemo-resistance

26-Feb-2016 - Despite numerous advances in oncology since the War on Cancer began, many patients develop resistance to standard therapies and eventually relapse. Moffitt Cancer Center researchers hope to improve treatment outcomes with development of a novel therapeutic strategy, called adaptive therapy, which ...

Oxytocin has social, emotional and behavioral benefits in young kids with autism

30-Oct-2015 - A five week treatment with the synthetic hormone oxytocin significantly improved social, emotional and behavioral issues among young children with autism, according to University of Sydney research. The study, led by researchers at the University's Brain and Mind Centre, is thought to be the ...

Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe

02-Aug-2010 - Bionovo, Inc. announced that it has received final guidance from the European Medicines Agency (EMA) in order to advance Menerba, the company's lead drug candidate for menopausal symptoms, to Phase 3 clinical trials in Europe. The guidance defines the clinical and regulatory pathway to a European ...

Large-scale genomic analysis of prostate cancer unveiled

28-Jun-2010 - A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Center (MSKCC) has yielded the most comprehensive genomic analysis of prostate cancer to date. "Genomic studies in other cancer types have resulted in new drug targets and strategies to classify patients into ...

Study suggests that tocotrienol has a common cancer-killing mechanism for different cancer types

12-Apr-2010 - Researchers from Davos Life Science in Singapore, in collaboration with scientists at the University of Hong Kong, have shown that gamma-tocotrienol, a member of the vitamin E family, is potent in killing prostate tumour cells in animal model studies. This research was reported in Pharmacology. ...

Hormone refractory prostate cancer: New studies in Austria

31-Mar-2010 - The Medical University of Vienna has been commissioned by international pharmaceutical firms to conduct three clinical trials of the treatment of recurrent prostate tumors (hormone refractory prostate carcinomas). The new approaches comprise immunotherapy, hormone therapy and an augmented form of ...

Hormone therapy may confer more aggressive properties to prostate tumors

11-Jun-2009 - Hormone therapy is often given to patients with advanced prostate cancer. While it is true that the treatment prevents growth of the tumour, it also changes its properties. Some of these changes may result in the tumour becoming more aggressive and more liable to form metastases. This is one of ...

Reproductive factors may protect women from Parkinson's disease

03-Mar-2009 - A large new study provides evidence that longer exposure to the body's own hormones may protect women from Parkinson's disease. The study will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009. The study found that women who have more ...